Product correctly added to cart.

discount label
No image
View 3D

Targetmol logo

Bupivacaine

CAS: 38396-39-3

Ref. TM-T0030L

50mg
39.00 €
100mgTo inquire
1ml*10 (DMSO)
56.00 €
Estimated delivery in United States, on Monday 13 May 2024

Product Information

Name:
Bupivacaine
Synonyms:
  • AH 250, AH-250, AH250, Bupivacaina, Exparel, Anekain
  • (.+-.)-1-Butyl-N-(2,6-dimethylphenyl)piperidin-2-carboxamid
  • (.+-.)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
  • (.+-.)-1-butil-N-(2,6-dimetilfenil)piperidina-2-carboxamida
  • (.+-.)-Bupivacaine
  • 1-Butyl-2',6'-pipecoloxylidide
  • 1-Butyl-2′,6′-pipecoloxylidide
  • 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
  • <span class="text-smallcaps">DL</span>-Bupivacaine
  • Anekain
  • See more synonyms
  • Bucain
  • Bupivan
  • Carbostesin
  • DL-Bupivacaine
  • Exparel
  • Marcaine
  • RS-Bupivacaine
  • Sky 0402
  • Win 11318
  • dl-1-Butyl-2',6'-pipecoloxylidide
Description:

Bupivacaine (AH-250) is a NMDA receptor inhibitor.Bupivacaine can block sodium, L-calcium, and potassium channels.Bupivacaine potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine can be used for the research of chronic pain.

Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
288.43
Formula:
C18H28N2O
Purity:
100%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-T0030L Bupivacaine

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".